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Resveratrol is a stilbene-type bioactive molecule with a broad spectrum of reported biological 
effects. In this sense, the current work provides a comprehensive literature analysis on resveratrol, 
representing a highly-researched commercially available dietary ingredient. Bibliometric data 
were identified by means of the search string TOPIC=(“resveratrol*”) and analyzed with the 
VOSviewer software, which yielded 17,561 publications extracted from the Web of Science Core 
Collection electronic database.  The ratio of original articles to reviews was 9.5:1. More than half of 
the overall manuscripts have been published since 2013. Major contributing countries were USA, 
China, Italy, South Korea, and Spain. Most of the publications appeared in journals specialized in 
biochemistry and molecular biology, pharmacology and pharmacy, food science technology, cell 
biology, or oncology. The phytochemicals or phytochemical classes that were frequently mentioned 
in the keywords of analyzed publications included, in descending order: resveratrol, trans-
resveratrol, polyphenols, flavonoids, quercetin, stilbenes, curcumin, piceatannol, cis-resveratrol, 
and anthocyanins.
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Resveratrol (systematically named 3,5,4’-trihydroxy-trans-stilbene) is a 
phytoalexin stilbenoid [Akinwumi et al. 2018] mainly found in the skin of grapes and 
many other dietary plants such as raspberries, mulberries, pistachios and peanuts. It is 
hypothesized that resveratrol is produced in response to stress conditions, including 
injury and microbial attack [Jang et al. 1997, Frémont 2000, Rocha‐González et al. 
2008, Tabeshpour et al. 2018]. Numerous investigations have reported its potential 
usefulness in the prevention and treatment of cardiovascular diseases, hepatic disorders, 
diabetes, cancer, obesity, pain, inflammation, tissue injury, neurodegeneration, and even 
aging [Rocha‐González et al. 2008, Bishayee et al. 2010b, Darvesh et al. 2010, Chachay 
et al. 2011, Sinha et al. 2016, Ko et al. 2017, Öztürk et al. 2017, Koushki et al. 2018, 
Pannu and Bhatnagar 2019, Springer and Moco 2019]. The antioxidant properties of 
resveratrol promote the reduction of arterial stiffness, which is a factor contributing to 
the development of cardiovascular diseases [Mozos and Luca 2017, Mozos et al. 2017, 
Wang et al. 2018, Uhrin et al. 2018]. Resveratrol has been considered responsible for 
the “French paradox”, explaining the comparatively low incidence of coronary heart 
disease despite consumption of high fat diet in France, where higher amounts of red 
wine (rich of resveratrol) are consumed [Kopp 1998]. In relation to the latter, it has 
been argued that resveratrol`s bio-effects are observed at concentrations higher than 
the concentrations typically found in red wine, but important consideration also is the 
synergistic action of resveratrol with other compounds found in red wine [Chan et al. 
2000, Kurin et al. 2012]. Additionally, the antidiabetic, antiviral and anti-microbial 
activity of resveratrol are also well documented [Koushki et al. 2018]. Because of its 
multiple potential health benefits, resveratrol is a frequently mentioned phytochemical 
in natural product research [Yeung et al. 2018a]. This compound is also present in varied 
and ever-growing nutraceuticals and food supplements [Santini et al. 2013, Andrew and 
Izzo 2017, Santini et al. 2017, Durazzo et al. 2018, Santini et al. 2018]. Resveratrol 
exists in two isomeric forms, i.e., the cis- and trans-isomer, both of which can be bound 
to glucose [Mattivi et al. 1995]. Trans-resveratrol is supposed to be present in grape 
skins, whereas cis-resveratrol is found in red wine, in variable concentration [López-
Hernández et al. 2007]. Though only trans-resveratrol is commercially available as a 
purified nutraceutical, the pharmacokinetic and pharmacodynamic properties of both 
isomers appear to be similar [Orallo 2006]. Resveratrol has been found to activate human 
SIRT1 (sirtuin 1) protein, which mediates anti-proliferative and anti-inflammatory 
activities via gene expression alterations and metabolic pathway modulations and 
thus exhibits many potential beneficial health effects [Borra et al. 2005, Mohar and 
Malik 2012, Ajami et al. 2017, Deus et al. 2017, Cătană et al. 2018, Humieniecki 
and Horbańczuk 2018, Mohan et al. 2018]. On the other hand, the bioavailability of 
resveratrol is poor because of its rapid metabolism leading to high concentrations of its 
metabolites in plasma [Chachay et al. 2011, Pannu and Bhatnagar 2019].
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With the large number of available publications, our literature analysis could 
identify major research topics, and also summarize and categorize the citation data 
of contributors from different levels (institutions, countries, and journals) and topics. 
Similar analyses have already been performed for the fields of ethnopharmacology 
[Yeung et al. 2018c], food sciences [Yeung 2018], nutraceuticals [Yeung et al. 2018d], 
neuropharmacology [Yeung et al. 2018e, Yeung et al. 2019a], and oncology [Yeung 
et al. 2018b].
The current analysis was aimed at evaluating research publications on resveratrol 
to identify the major contributing institutions, countries/regions, and journals. Another 
purpose of this work was to identify the major research topics of resveratrol literature, 
and reveal the chemicals/chemical classes that were frequently co-investigated and 
discussed along with resveratrol.
Material and methods
In December 2018, we accessed the Web of Science (WoS) Core Collection 
electronic database (Clarivate Analytics, Philadelphia, PA, USA) to identify 
publications containing the word “resveratrol” or its derivatives in the title, abstract, 
or keywords using for this purpose the search string: TOPIC=(“resveratrol*”). Since 
the chemical formula of resveratrol is 3,5,4’-trihydroxy-trans-stilbene, we conducted 
an exploratory search to assess if we missed some publications that only listed the 
chemical formula but not the word “resveratrol” itself or its derivatives. For this 
purpose, we used the search string: TOPIC=(“3,5,4’-trihydroxy-trans-stilbene”) NOT 
TOPIC=(“resveratrol*”), which yielded no results, thus confirming that our initial 
approach was correct. No extra restriction was considered on the search strategy, such 
as publication language or publication year.
Data extraction
The publications identified from the search were evaluated for (1) publication 
year; (2) author’s affiliations; (3) country/region of the affiliations; (4) journal title; 
(5) WoS category; (6) publication type; (7) language; and (8) total citation count. The 
full records and cited references of these identified publications were extracted and 
analyzed by the VOSviewer software for bibliometrics.
The VOSviewer software was also applied to analyze the semantic contents of 
titles, abstracts, and keywords of publications in order to relate them to the citation 
data count and synthesize a bubble map to visualize the results [van Eck and Waltman 
2009]. For the current work, we used default settings of the software for the analyses 
and syntheses of the bubble map. The bubble size in the bubble map indicates the 
frequency of occurrence (multiple appearances in a single publication count as one) of 
the words. Words are clustered if they co-occurred in the analyzed publications more 
frequently. Only words that appeared in at least 1% (n = 176) of the publications were 
analyzed and visualized.
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Results and discussion
The literature search resulted in 17,561 publications. The earliest resveratrol-
related publication indexed in WoS dated from 1976, and investigated the production of 
resveratrol by plants of the family Vitaceae in response to infection or injury [Langcake 
and Pryce 1976]. More than half of the overall publications has been published since 
the year 2013 of which a large number originates from China (publications since 2013 
= 2,407; 72.9% of China’s total publications), which reflects the increasing research 
interest in natural products in general [Atanasov et al. 2015]. The ratio of original 
articles (n = 13,821) to reviews (n = 1,459) was 9.5:1. Most of the publications were 
written in English (n = 17,348; 98.8%). Contributions came from 7,720 institutions 
(authors’ affiliations) located in 135 countries/territories and were published in 2,751 
different journals. The top five WoS categories of the publications were biochemistry 
and molecular biology (n = 2,850; 16.2%), pharmacology and pharmacy (n = 2,723; 
15.5%), food science technology (n = 1,980; 11.3%), cell biology (n = 1,443; 
8.2%), and oncology (n = 1,361; 7.8%). Top five contributors with regard to journal, 
institution and country/territory are listed in Table 1. In particular, we noticed that the 
number of publications that appeared in the journal Molecules largely increased after 
2013 due to the introduction of its “Metabolites” section, together with its open access 
policy and apparent preference for Chinese researchers. Though the French National 
Institute of Health and Medical Research is the largest contributing institution, France 
was not within the top 5 countries. The large number of contributions from the USA, 
China and Italy was similar to their respective shares in the fields of antioxidant, 
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 Table 1. Top five contributor journals, institutions, and countries/territories of the analyzed 17,561 publications 
 
Contributor  Publication count (% of total)  
Citation per 
manuscript 
Journal     
Journal of Agricultural and Food Chemistry  432 (2.5%)  51.7 
PLOS One  313 (1.8%)  26.7 
FASEB Journal  292 (1.7%)  17.4 
Food Chemistry  239 (1.4%)  30.5 
Molecules  170 (1.0%)  12.3 
     
Institution     
French National Institute of Health and Medical Research   267 (1.5%)  57.3 
National Institutes of Health (USA)  244 (1.4%)  83.5 
University of California  243 (1.4%)  54.2 
National Research Council (Italy)  206 (1.2%)  46.5 
University of Texas  198 (1.1%)  76.6 
     
Country / Territory     
USA    4,148 (23.6%)  44.8 
China    3,300 (18.8%)  15.5 
Italy    1,277 (7.3%)  33.2 
South Korea    1,042 (5.9%)  23.5 
Spain    1,027 (5.8%)  38.9 
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ethnopharmacology, and natural products research [Yeung et al. 2018a, Yeung et al. 
2018b, Yeung et al. 2018c, Yeung et al. 2019b]. 
There were 422 terms that appeared in at least 1% (n = 176) of the analyzed 
titles and abstracts (Fig. 1). Some major themes were related to: treatment (n = 4,555, 
citations per publication; CPP = 26.4), mechanism (n = 3,479; CPP = 35.0), apoptosis 
(n = 2,159; CPP = 33.4), cancer (n = 1,840; CPP = 39.5), diet (n = 1,021; CPP = 45.5), 
oxidative stress (n = 1,656; CPP = 28.9), inflammation (n = 1,179; CPP = 33.0), and 
antioxidant (n = 1,064; CPP = 35.7). 
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Fig. 1. Bubble map visualizing words from titles and abstracts of the 17,561 resveratrol publications. Only 
words that appeared in at least 1% (n = 176) of the publications’ titles and abstracts were analyzed and 
visualized by VOSviewer software. There were 422 terms that appeared in at least 1% of the analyzed 
publications. The bubble color indicates the averaged citations received by publications with the specific 
words. The bubble size indicates the appearance frequency of the words (multiple appearances in a single 
manuscript count as one). Two words are closer to each other if they co-occurred more frequently in the 
analyzed publications.
There were 133 keywords that were used in at least 1% of the publications (Fig. 2). 
It could be observed that in vitro (n = 1,474; CPP = 26.1) was listed in more publications 
as a keyword than in vivo (n = 640; CPP = 30.3), with mice (n = 822; CPP = 23.3) 
and rats (n = 637; CPP = 24.7) being the most common animal models. Some of the 
most commonly mentioned diseases or conditions were Alzheimer’s disease (n = 404; 
CPP = 32.5), breast cancer (n = 303; CPP = 29.9), obesity (n = 289; CPP = 24.4), 
atherosclerosis (n = 257; CPP = 45.1), and coronary heart disease (n = 180; CPP = 56.5). 
The most frequent sources of studied dietary resveratrol were red wine (n = 1,142; CPP 
= 47.0), grapes (n = 398; CPP = 41.0), and green tea (n = 180; CPP = 45.5). Concerning 
the natural sources from which resveratrol is extracted, only the plant Latin name Vitis 
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vinifera L. (n = 270, CPP = 32.1) was present among these 133 keywords that were used 
in at least 1% of the publications. Many different plant species, whose names were not 
found in the 133 keywords list, are also known to contain resveratrol. These include 
food crops like strawberry (Fragaria x ananassa (Duchesne ex Weston) Duchesne ex 
Rozier (Rosaceae)); raspberry (Rubus idaeus L. (Rosaceae)); blackberry (Rubus spp. 
(Rosaceae)); blueberry (Vaccinium spp. (Ericaceae)) [Schröder and Schröder 1990, 
Rimando et al. 2004, Wang et al. 2007, Jeong et al. 2016], as well as some wild plants 
such as Lycium chilense Bertero (Solanaceae) [Varela et al. 2016], and Helichrysum 
spp. (Compositae) [Albayrak et al. 2010].
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Fig. 2. Bubble map visualizing keywords of the 17,561 resveratrol publications. Only keywords (author 
keywords and Web of Science KeyWords Plus) that appeared in at least 1% (n = 176) of the publications 
were analyzed and visualized by VOSviewer software. There were 133 keywords that appeared in at 
least 1% of the analyzed publications. The bubble color indicates the averaged citations received by 
publications with the specific keywords. The bubble size indicates the appearance frequency of the words 
(multiple appearances in a single manuscript count as one). Two words are closer to each other if they co-
occurred more frequently in the analyzed publications.
Phytochemicals or compound classes that were frequently mentioned in the 
keywords of analyzed publications included, in descending order, resveratrol (n = 
9,524; CPP = 25.9), trans-resveratrol (n = 1,809; CPP = 39.5), polyphenols (n = 1,045; 
CPP = 33.6), flavonoids (n = 597; CPP = 38.9), quercetin (n = 520; CPP = 37.3), 
stilbenes (n = 407; CPP = 42.7), curcumin (n = 323; CPP = 33.7), piceatannol (n = 
224; CPP = 25.5), cis-resveratrol (n = 215; CPP = 50.0), and anthocyanins (n = 213; 
CPP = 31.6) (Fig. 3).
In the analyzed literature set, numerous publications investigated the beneficial 
effect of resveratrol on animal health or animal models of disease. Among other reported 
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Fig. 3. Chemical structures of key single chemicals or representatives of chemical classes that were often 
discussed in the analyzed resveratrol-related publications.
effects, it has been found that resveratrol exerts analgesic and anti-inflammatory 
activities in mice and rats [Wang et al. 2017]. Resveratrol also improved the health 
and survival of mice on a high-calorie diet [Baur et al. 2006], which led to the 
inference that health-beneficial effects of resveratrol are similar to those achieved by 
calorie restriction (CR) and mediated through induction of autophagy, an intracellular 
catabolic process that maintains cell survival under stressful conditions [Dutta 
et al. 2014, Moosavi et al. 2018]. A combination of CR and resveratrol improved 
cardiovascular health in 26-month-old rats [Dutta et al. 2014]. In addition, resveratrol 
was also found to exert a protective effect against the toxicity of dioxins to which 
larvae of Drosophila melanogaster were exposed [Çolak and Uysal 2017]. On the 
other hand, however, resveratrol has also been associated with harms to animal health. 
For example, resveratrol has been linked to promoting atherosclerosis in rabbits fed 
with high cholesterol diet [Wilson et al. 1996]. Concerning its anti-cancerous effect, 
animal studies have yielded mixed results, depending on the route of administration, 
dose, tumor model, and species [Carter et al. 2014].
The dose of resveratrol needed for physiological adaptations in humans is different 
from that required for animals [Lagouge et al. 2006]. This may be attributable to 
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the difference in the metabolism rate of resveratrol between humans and animals 
[Hsieh and Wu 2010, Kuršvietienė et al. 2016]. Recent reviews have encouraged the 
conduction of better designed studies conducting more human clinical trials, as current 
evidence is scant and does not always confirm the beneficial effects reported from in 
vitro and animal studies [Bishayee 2009, Smoliga et al. 2011, Tomé-Carneiro et al. 
2013, Singh et al. 2015, Berman et al. 2017, Ramírez-Garza et al. 2018]. For example, 
clinical studies conducted on patients diagnosed with cancer yield ambiguous results, 
depending on the type of cancer [Berman et al. 2017]. Results from a phase 2 trial 
of resveratrol tested on patients with mild to moderate Alzheimer’s disease revealed 
that resveratrol was safe and well-tolerated and could penetrate the blood-brain 
barrier (BBB) to have effects on the central nervous system (CNS) [Turner et al. 
2015, Terawi et al. 2018]. One particular problem encountered is the dose translation 
from animal models to humans, for which no gold standard is yet available. The body 
surface area normalization method rather than a simple conversion by body weight 
is a preferable standard [Reagan-Shaw et al. 2008]. A high absorption accompanied 
by a low bioavailability of resveratrol through oral ingestion in humans is yet 
another downside [Walle et al. 2004]. All of these factors imply that more efforts are 
necessary to evaluate the promising beneficial effects, especially anti-inflammatory, 
chemopreventive and anticancer therapeutic activities of resveratrol, observed in 
multiple in vitro and in vivo models [Jang et al. 1997, Manna et al. 2000, Ashikawa 
et al. 2002, Banerjee et al. 2002, Estrov et al. 2003, Aggarwal et al. 2004, Bhardwaj 
et al. 2007, Harikumar and Aggarwal 2008, Bishayee and Dhir 2009, Shakibaei et al. 
2009, Bishayee et al. 2010a, Bishayee et al. 2010c, Harikumar et al. 2010, Gupta et al. 
2011, Mbimba et al. 2012, Buhrmann et al. 2017, Humieniecki et al. 2017, Buhrmann 
et al. 2018, Islam et al. 2018, Mozos et al. 2018, Wang et al. 2018]. 
No analysis was conducted on the authorship of resveratrol publications, as many 
of the most abundant authors had Chinese names, which shared the same initials, thus 
complicating an accurate analysis. For instance, according to the data analyzed, the most 
prolific author for the analyzed resveratrol publications was “Zhang Y.”, which name 
upon a closer examination revealed to represent multiple authors: Zhang Yongqing, 
Zhang Yan, Zhang Yong, and a few others. Analyzing authorship by full names was also 
not feasible since some records only listed the authors’ first names as initials.
Conclusions
The findings based on the analysis of the publications on resveratrol revealed that 
some of the most significant contributors came from the USA, China, Italy, South Korea, 
and Spain. Most of the publications focused on biochemistry and molecular biology, 
pharmacology and pharmacy, food science technology, cell biology, or oncology. More 
than 50% of them have been published since 2013, which could be attributed in part to 
the increased research activity in China. Frequently investigated diseases or conditions 
included Alzheimer’s disease, breast cancer, obesity, atherosclerosis, and coronary heart 
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disease. This work could be used for a brief overview of resveratrol-related research 
landscape, in order to identify open windows for future research on resveratrol or its 
derivatives.
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